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TCT-629
Comparison of Optical Coherence Tomography and Histopathology Findings
Following Paclitaxel-Coating Balloon in Porcine In-stent Stenosis Model
Arihiro Sumida1, Alexander Nikanorov2, Toshiro Shinke1, Jinsheng Li1, Jaipal Singh1,
Spencer King1, Nicolas Chronos1, Dongming Hou1
1SJTRI, Atlanta, GA; 2Abbott Vascular, Santa Clara, CA, CA
Background: Paclitaxel-Coating balloon (PCB) has shown efficacy for treatment of
coronary artery disease. Optical coherence tomography (OCT) is a promising
endovascular imaging devise and has been reported to have a high correlation with
histomorphometric measurement. However, the association of in-stent stenosis (ISR)
by OCT and histopathology response is still not fully addressed. The current study was
designed to compare the OCT and histopathological findings following PCB treatment
in a porcine ISR model.
Methods: Thirty-two coronary arteries (LAD: n=12, LCX: n=11, RCA: n=9) of 24
Yorkshire pigs were assigned to two (2) groups randomly. PCB (SeQuent, length
20mm, n=16) or non-coating balloon (NCB, length 20mm n=16) were inflated for 60
seconds with B:A 1.2:1 followed by BMS (length 12mm) implantation (S/A 1.5:1)
within the target region. At 28 days, animals underwent OCT and histopathology
evaluation.
Results: There were no significant differences between groups among parameters
measured by OCT. The thickness of neointimal hyperplasia on stent strut and the
percent of ISR were 585 ± 277 μm, 46.8 ± 19.0 % for PCB, and 661 ± 237 μm, 52.4
± 15.3 % for NCB (p=NS, respectively). However, inflammation (PEB: 3.40 ± 0.84,
NCB: 2.27 ± 1.18, p=0.003) and fibrin deposition scores (PCB: 2.31 ± 0.93, NCB:
0.81 ± 0.86, p<0.001) were significantly higher in PCB compared to NCB. The OCT
ISR% was positively correlated with inflammation score (PCB: r=0.62, and NCB:
r=0.85; p<0.05 respectively). Interestingly, fibrin deposition score only in PCB was
negatively correlated with the OCT ISR% (r=-0.68, p=0.005). OCT also showed an
uncovered (33.3%) and insufficient non-uniformed neointima (13.3%) in PCB group
(p=0.008 vs NCB).
Conclusion: OCT can be used as a valuable imaging tool to evaluate vessel wall
histopathological changes in vivo. The higher inflammation and fibrin deposition
scores in PCB may indicate a delayed healing response in the current experimental
setting.
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Does measurement of serum 1,5-anhydroglucitol (1,5-AG) level be able to
predict the presence of coronary plaque?
Suguru Murase, Osamu Matsuda, Akira Murata, Yoriyasu Suzuki, Tatsuya Fukutomi,
Tetsuo Matsubara
Nagoya heart center, Nagoya, Japan
Background: The postprandial hyperglycemia is well known as one of the risk factors
for cardiovascular disease. Serum 1,5-Anhydroglucitol (1,5-AG) is a useful clinical
marker for short-term glycemic status and postprandial hyperglycemia. We examined
whether serum 1,5-AG level can predict the presence of coronary plaque.
Methods: We investigated the relationship between serum 1,5-AG level and coronary
plaque in 513 consecutive patients evaluated by 128-slice CT. In those patients, 126
cases have taken coronary artery angiography (CAG). We compared the presence of
coronary plaque by MSCT and Syntax score of patients with CAG between patients
with serum 1,5-AG level less than 14μg/ml and over 14μg/ml.
Results: The table has shown in table. The level of serum 1,5-AG seems to have the
correlation and severity of coronary artery plaque/stenosis.
Conclusion: Our findings demonstrate that the relationship between the presence of
coronary plaque and serum 1,5-AG level was much better than that of HbA1c.
Measurement of serum 1,5-AG level might help to diagnose the presence of coronary
artery plaque in routine clinical practice.
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Correlation between modification in plaque composition and changes in
vascular geometry at the edges of bare metal and drug-eluting stents
Jose De Ribamar Costa, Alexandre Abizaid, Dimytri Siqueira, Daniel Chamie,
Ricardo Costa, Rodolfo Staico, Fausto Feres, Amanda Sousa, J Eduardo Sousa
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Background: To the present, little is known about the correlation between
modifications in plaque composition at stent edges and the changes in vessel geometry.
This study sought to evaluate, by serial grey-scale intravascular ultrasound (IVUS)
and Virtual Histology™, the modifications in plaque composition at the edges of drug-
eluting (DES) and bare-metal stents (BMS) and the correlation of these findings with
changes in the measuremntes of vessel, lumen and plaque area at those segments.
Methods: Single-center, prospective and randomized (1:1) evaluation of 40 patients
with acute coronary syndrome treated with BMS (Driver, n=20 patients) or DES
(Cypher, n=20 patients). Following stent deployment, all individuals underwent gray
scale IVUS and Virtual Histology™ evaluation, which were repeated at nine months.
Primary endpoint was the modification in vessel, lumen and plaque area and in the
composition of the plaque in the mean time between the baseline and follow-up
procedure. Additionally, we sought to correlate the variation in plaque composition
and changes in vessel geometry.
Results: Baseline clinical and angiographic characteristics did not differ between
groups. At the proximal edge of DES and BMS there was a trend to positive vessel
remodeling which compensated the modest increase in plaque area. At the distal edge,
patients treated with DES had less plaque growth resulting in a larger lumen area at
follow-up. By Virtual Histology, there was a marked reduction in the % of fibrotic
tissue and necrotic core in both edges of the two stents and a positive, strong correlation
was seen between increase in % of fibrofatty component and augmentation in plaque
area (r=0.78, p=0.01).
Conclusion: The use of DES was not associated with “edge effect”. On the contrary,
patients treated with these devices experienced less plaque growth, especially at the
distal edge of the stents. Modifications in plaque composition, with increase in
fibrofatty content, might partially explain these findings.
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Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of
Neointimal Distribution by Optical Coherence Tomography
Hiromasa Otake, Toshiro Shinke, Junya Shite, Masayuki Nakagawa, Ryoji Nagoshi,
Tsuyoshi Osue, Ken-ichi Hirata
Kobe University Graduate School of Medicine, Kobe, Japan
Background: TAXUS Express™ paclitaxel-eluting stent (PES) and TAXUS Liberté™
PES consist of the same drug, drug dose, and polymer, but have different stent
platforms. TAXUS Liberté™ PES has a thinner stent strut platform specifically
designed for more uniform drug elution. The aim of this study was to assess the impact
of stent design and strut thickness on vessel healing after PES deployment.
Methods: Fifty-four patients who underwent 6-month follow-up optical coherence
tomography (OCT) after TAXUS Express™ (n=27) or TAXUS Liberté™ PES (n=27)
implantation were enrolled. In addition to standard OCT variables, longitudinal and
circumferential uniformity of neointimal distribution was evaluated in 3-dimensions
by computing mean neointimal thickness (NIT) within 360 equally-spaced radial
sectors for every 1-mm cross-section along the stented segment. The incidence of stents
with a peri-strut low intensity area (PLIA), a finding suggestive of delayed arterial
healing, was also evaluated.
Results: TAXUS Liberté™ PES had a significantly thinner mean NIT than the TAXUS
Express™ PES with comparable frequency of uncovered struts. Longitudinal and
circumferential absolute variation of NIT expressed by standard deviation of NIT
calculated from each sector was significantly smaller for the TAXUS Liberté™ PES
than for the TAXUS Express™ PES. TAXUS Liberté™ PES had a tendency toward a
decreased incidence of thrombus and struts with PLIA than the TAXUS Express™
PES.
Comparisons between TAXUS Liberté PES vs. TAXUS Express PES
Conclusion: Stent design and thickness appeared to impact vessel healing of PES. The
stent platform of TAXUS Liberté™ PES may offer greater and more homogeneous
neointima suppression in patients treated with PES.
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